The Impact of Dermatologic Adverse Events on the Quality of Life of Oncology Patients: A Review of the Literature

Belzer, Annika; Pach, Jolanta J.; Valido, Kailyn; Leventhal, Jonathan S.

doi:10.1007/s40257-024-00847-2

Cited by 3 publications

(1 citation statement)

References 58 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…With more people with cancer living longer, improving patients' quality of life (QoL) becomes paramount. Dermatologic adverse events secondary to oncological therapy are common and negatively impact patients' QoL, affecting psychosocial well-being, body image, and social interactions [ 6 ]. This recognition highlights the significant role of aesthetic treatments in mitigating the physical and psychological consequences of cancer therapies, thereby contributing to patients' improved well-being [ 7 ].…”

Section: Introductionmentioning

confidence: 99%

18F-FDG PET-CT Scans in Oncology Patients Treated with Hyaluronic Acid Filler: Not Always a Pitfall

Proietti,

Battilotti,

Svara

et al. 2024

Case Reports in Oncological Medicine

View full text Add to dashboard Cite

The use of hyaluronic acid (HA) fillers in oncology patients undergoing PET-CT scans is a topic of debate due to potential interference with imaging accuracy. A 54-year-old female, postmelanoma metastasectomy in the parotid region with subsequent facial nerve palsy (FNP), received HA filler injections for facial symmetry and functional restoration. Follow-up PET-CT scans showed no interference or artifacts attributable to HA injection, allowing for accurate imaging results. This case suggests that HA fillers administered in oncology patients may not universally pose challenges or disrupt PET-CT imaging interpretation. Due to the possible false positives induced by fillers, the inclusion of aesthetic treatments in patients’ anamnesis is a crucial step to accurately interpret PET-CT images. Although maintaining high level of caution in interpreting PET-CT results after filler injection is essential, our case emphasizes the safety of this procedure in oncology patients undergoing follow-up PET-CT scans.

show abstract

Section: Introductionmentioning

confidence: 99%